<html>
<head>


  </head>
<body lang="EN-US">
<div style="font-family:Times New Roman;">
<div style="border-bottom:solid windowtext 1.0pt;border-left:none;border-right:none;border-top:solid windowtext 3.0pt;padding:1.0pt 0in 1.0pt 0in;">
<p style="border:none;margin:0in 0in .0001pt;padding:0in;"><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
</div>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="5" face="Times New Roman" style="font-size:18.0pt;font-weight:bold;">UNITED STATES</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="5" face="Times New Roman" style="font-size:18.0pt;font-weight:bold;">SECURITIES AND EXCHANGE COMMISSION</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Washington, D.C. 20549</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="5" face="Times New Roman" style="font-size:18.0pt;font-weight:bold;">FORM&nbsp;8-K</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="3" face="Times New Roman" style="font-size:12.0pt;font-weight:bold;">CURRENT REPORT</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="3" face="Times New Roman" style="font-size:12.0pt;font-weight:bold;">Pursuant to Section&nbsp;13 or 15(d)&nbsp;of the Securities Exchange Act of 1934</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Date of Report (Date of earliest event reported):&#160; <b>July&nbsp;3, 2013</b></font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="5" face="Times New Roman" style="font-size:18.0pt;font-weight:bold;">LANTHEUS MEDICAL IMAGING,&nbsp;INC.</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Exact name of registrant as specified in its charter)</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div align="center">
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
<tr>
<td width="34%" valign="top" style="padding:0in 0in 0in 0in;width:34.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Delaware</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="31%" valign="top" style="padding:0in 0in 0in 0in;width:31.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">333-169785</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="31%" valign="top" style="padding:0in 0in 0in 0in;width:31.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">51-0396366</font></b></p>    </td>   </tr>
<tr>
<td width="34%" valign="top" style="padding:0in 0in 0in 0in;width:34.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(State or   other jurisdiction of incorporation)</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="31%" valign="top" style="padding:0in 0in 0in 0in;width:31.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Commission   File Number)</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="31%" valign="top" style="padding:0in 0in 0in 0in;width:31.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(IRS   Employer Identification No.)</font></p>    </td>   </tr>  </table>
</div>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">331 Treble Cove Road, North Billerica, MA 01862</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Address of principal executive offices) (Zip code)</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Registrant&#146;s telephone number, including area code:<b>&#160; (978) 671-8001</b></font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Not Applicable</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Former name or former address, if changed since last report.)</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Check the appropriate box below if the Form&nbsp;8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font><font size="2" style="font-size:10.0pt;"> Written communications pursuant to Rule&nbsp;425 under the Securities Act (17 CFR 230.425)</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font><font size="2" style="font-size:10.0pt;"> Soliciting material pursuant to Rule&nbsp;14a-12 under the Exchange Act (17 CFR 240.14a-12)</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font><font size="2" style="font-size:10.0pt;"> Pre-commencement communications pursuant to Rule&nbsp;14d-2(b)&nbsp;under the Exchange Act (17 CFR 240.14d-2(b))</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font><font size="2" style="font-size:10.0pt;"> Pre-commencement communications pursuant to Rule&nbsp;13e-4(c)&nbsp;under the Exchange Act (17 CFR 240.13e-4(c))</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="border-bottom:solid windowtext 3.0pt;border-left:none;border-right:none;border-top:solid windowtext 1.0pt;padding:1.0pt 0in 1.0pt 0in;">
<p style="border:none;margin:0in 0in .0001pt;padding:0in;"><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
</div>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\C901531\13-16368-1\task6128421\16368-1-ba.htm',USER='C901531',CD='Jul 10 21:48 2013' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 1.0in;text-indent:-1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Item 1.01</font></b><b><font size="1" style="font-size:3.0pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font></b><b><font size="2" style="font-size:10.0pt;font-weight:bold;">Entry into a Material Definitive Agreement.</font></b></p>
<p style="margin:0in 0in .0001pt 1.0in;text-indent:-1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">On July&nbsp;3, 2013, the registrant, Lantheus Medical Imaging,&nbsp;Inc. (the &#147;Company&#148;), entered into an Amended and Restated Credit Agreement dated as of July&nbsp;3, 2013 (the &#147;New Facility&#148;), by and among the Company, as borrower, Lantheus MI Intermediate,&nbsp;Inc., the </font><font size="2" style="font-size:10.0pt;">immediate</font><font size="2" style="font-size:10.0pt;"> parent of the Company (&#147;Lantheus Intermediate&#148;)</font><font size="2" style="font-size:10.0pt;"> and</font><font size="2" style="font-size:10.0pt;"> Lantheus MI Real Estate, LLC, a subsidiary of the Company (&#147;Lantheus Real Estate&#148;), each as guarantors, and Wells Fargo Bank, National Association, a national banking association (&#147;Wells Fargo&#148;), as sole </font><font size="2" style="font-size:10.0pt;">lead arranger, bookrunner, administrative agent and syndication agent</font><font size="2" style="font-size:10.0pt;">, </font><font size="2" style="font-size:10.0pt;">consisting of a revolving credit facility in an aggregate principal amount not to exceed </font><font size="2" style="font-size:10.0pt;">$42.5 million.&#160; </font><font size="2" style="font-size:10.0pt;">The revolving loans </font><font size="2" style="font-size:10.0pt;">under the New Facility bear interest </font><font size="2" style="font-size:10.0pt;">subject to a pricing grid based on average historical excess availability under the New Facility, with pricing based from time to time at the election of the Company at (i)&nbsp;</font><font size="2" style="font-size:10.0pt;">LIBOR plus </font><font size="2" style="font-size:10.0pt;">a spread ranging from 2.00% to 2.50%</font><font size="2" style="font-size:10.0pt;"> or</font><font size="2" style="font-size:10.0pt;"> (ii)&nbsp;</font><font size="2" style="font-size:10.0pt;">the Reference Rate (as defined in the agreement) plus </font><font size="2" style="font-size:10.0pt;">a spread ranging from 1.00% to 1.50%</font><font size="2" style="font-size:10.0pt;">.&#160; The New Facility also includes an unused line fee of 0.375% or 0.5%, depending on the average unused revolving credit commitments.&#160; The New Facility expires on </font><font size="2" style="font-size:10.0pt;">the earlier of (i)&nbsp;</font><font size="2" style="font-size:10.0pt;">July&nbsp;3, 2018</font><font size="2" style="font-size:10.0pt;"> or (ii)&nbsp;if the outstanding 9.750% senior notes due in 2017 are not refinanced in full, the date that is 91 days before the maturity thereof,</font><font size="2" style="font-size:10.0pt;"> at which time all outstanding borrowings are due and payable</font><font size="2" style="font-size:10.0pt;">.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The New Facility is secured by a pledge of substantially all of the </font><font size="2" style="font-size:10.0pt;">assets of each of the Company, Lantheus Intermediate and Lantheus Real Estate, including each such entity&#146;s inventory, accounts receivable and machinery and equipment</font><font size="2" style="font-size:10.0pt;">, </font><font size="2" style="font-size:10.0pt;">and is guaranteed</font><font size="2" style="font-size:10.0pt;"> by each of Lantheus Intermediate and Lantheus Real Estate.&#160; Borrowing capacity is determined by reference to a borrowing base</font><font size="2" style="font-size:10.0pt;">, which is based on (i)&nbsp;a percentage</font><font size="2" style="font-size:10.0pt;"> of </font><font size="2" style="font-size:10.0pt;">certain eligible</font><font size="2" style="font-size:10.0pt;"> accounts receivable, inventory</font><font size="2" style="font-size:10.0pt;"> and</font><font size="2" style="font-size:10.0pt;"> machinery and equipment minus </font><font size="2" style="font-size:10.0pt;">(ii)&nbsp;any </font><font size="2" style="font-size:10.0pt;">reserves.&#160; As of July&nbsp;3, 2013, the aggregate borrowing base was approximately $38.4 million, with an outstanding $9.2 million unfunded Standby Letter of Credit and an $8</font><font size="2" style="font-size:10.0pt;">.0</font><font size="2" style="font-size:10.0pt;"> million loan balance for net borrowing base availability of approximately $21.2 million.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The New Facility contains affirmative and negative covenants, as well as restrictions on the ability of Lantheus Intermediate, the Company and the Company&#146;s subsidiaries to: (i)&nbsp;incur additional indebtedness or issue preferred stock; (ii)&nbsp;repay subordinated indebtedness prior to its stated maturity; (iii)&nbsp;pay dividends on, repurchase or make distributions in respect of capital stock or make other restricted payments; (iv)&nbsp;make certain investments; (v)&nbsp;sell certain assets; (vi)&nbsp;create liens; (vii)&nbsp;consolidate, merge, sell or otherwise dispose of all or substantially all of the Company</font><font size="2" style="font-size:10.0pt;">&#146;</font><font size="2" style="font-size:10.0pt;">s assets; and (viii)&nbsp;enter into certain transactions with the Company</font><font size="2" style="font-size:10.0pt;">&#146;</font><font size="2" style="font-size:10.0pt;">s affiliates.&#160; The New Facility also contains customary default provisions as well as cash dominion provisions which allow the lender to </font><font size="2" style="font-size:10.0pt;">sweep</font><font size="2" style="font-size:10.0pt;"> the Company&#146;s accounts </font><font size="2" style="font-size:10.0pt;">during</font><font size="2" style="font-size:10.0pt;"> the period</font><font size="2" style="font-size:10.0pt;"> certain specified events of default are continuing </font><font size="2" style="font-size:10.0pt;">under the New Facility or excess availability under the New Facility falls below </font><font size="2" style="font-size:10.0pt;">(i)&nbsp;</font><font size="2" style="font-size:10.0pt;">15% of the then-current borrowing base</font><font size="2" style="font-size:10.0pt;"> for a period of more than five consecutive Business Days or (ii)&nbsp;$3.5 million</font><font size="2" style="font-size:10.0pt;">.&#160; </font><font size="2" style="font-size:10.0pt;">During</font><font size="2" style="font-size:10.0pt;"> a cash dominion period, the Company is required to comply with a consolidated fixed charge coverage </font><font size="2" style="font-size:10.0pt;">ratio </font><font size="2" style="font-size:10.0pt;">of not less than 1:00:1:00.&#160; The fixed charge coverage ratio is calculated </font><font size="2" style="font-size:10.0pt;">on a consolidated basis for Lantheus Intermediate and its subsidiaries for a trailing four-fiscal quarter period basis, </font><font size="2" style="font-size:10.0pt;">as (</font><font size="2" style="font-size:10.0pt;">i</font><font size="2" style="font-size:10.0pt;">)&nbsp;EBITDA minus capital expenditures minus certain restricted payments </font><font size="2" style="font-size:10.0pt;">divided by</font><font size="2" style="font-size:10.0pt;"> (</font><font size="2" style="font-size:10.0pt;">ii</font><font size="2" style="font-size:10.0pt;">)&nbsp;interest</font><font size="2" style="font-size:10.0pt;"> plus </font><font size="2" style="font-size:10.0pt;">taxes </font><font size="2" style="font-size:10.0pt;">paid or </font><font size="2" style="font-size:10.0pt;">payable</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2<a name="PB_2_003340_7056"></a></font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>
</div>
<!-- SEQ.=1,FOLIO='2',FILE='C:\JMS\C901531\13-16368-1\task6128421\16368-1-ba.htm',USER='C901531',CD='Jul 10 21:48 2013' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:3.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">in cash plus </font><font size="2" style="font-size:10.0pt;">certain restricted payments</font><font size="2" style="font-size:10.0pt;"> made in cash plus </font><font size="2" style="font-size:10.0pt;">scheduled principal payments</font><font size="2" style="font-size:10.0pt;"> paid or payable in cash</font><font size="2" style="font-size:10.0pt;">.</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3<a name="PB_3_003348_5335"></a></font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>
</div>
<!-- SEQ.=1,FOLIO='3',FILE='C:\JMS\C901531\13-16368-1\task6128421\16368-1-ba.htm',USER='C901531',CD='Jul 10 21:48 2013' -->

<br clear="all" style="page-break-before:always;">
<div>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">SIGNATURES</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
<tr>
<td width="47%" valign="top" style="padding:0in 0in 0in 0in;width:47.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="52%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:52.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">LANTHEUS MEDICAL   IMAGING,&nbsp;INC.</font></p>    </td>   </tr>
<tr>
<td width="47%" valign="top" style="padding:0in 0in 0in 0in;width:47.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="7%" valign="top" style="padding:0in 0in 0in 0in;width:7.08%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="45%" valign="top" style="padding:0in 0in 0in 0in;width:45.58%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="47%" valign="top" style="padding:0in 0in 0in 0in;width:47.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="7%" valign="top" style="padding:0in 0in 0in 0in;width:7.08%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">By:</font></p>    </td>
<td width="45%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:45.58%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">/s/ Michael P.   Duffy</font></p>    </td>   </tr>
<tr>
<td width="47%" valign="top" style="padding:0in 0in 0in 0in;width:47.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="7%" valign="top" style="padding:0in 0in 0in 0in;width:7.08%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Name:</font></p>    </td>
<td width="45%" valign="top" style="border:none;padding:0in 0in 0in 0in;width:45.58%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Michael P. Duffy</font></p>    </td>   </tr>
<tr>
<td width="47%" valign="top" style="padding:0in 0in 0in 0in;width:47.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="7%" valign="top" style="padding:0in 0in 0in 0in;width:7.08%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Title:</font></p>    </td>
<td width="45%" valign="top" style="padding:0in 0in 0in 0in;width:45.58%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Vice President and   Secretary</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Date:&#160; July&nbsp;10, 2013</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4<a name="PB_4_003528_5796"></a></font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>
</div>
<!-- SEQ.=1,FOLIO='4',FILE='C:\JMS\C901531\13-16368-1\task6128421\16368-1-ba.htm',USER='C901531',CD='Jul 10 21:48 2013' -->

</body>
</html>
[{"type": "8-K", "sequence": "1", "filename": "a13-16368_18k.htm", "description": "8-K", "secsgml_size_bytes": 25365}]
{"company-data": {"conformed-name": "Lantheus Medical Imaging, Inc.", "cik": "0001500157", "assigned-sic": "2834", "irs-number": "510396366", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "333-169785", "film-number": "13962147"}, "business-address": {"street1": "331 TREBLE COVE ROAD", "city": "NORTH BILLERICA", "state": "MA", "zip": "01862", "phone": "978-667-9531"}, "mail-address": {"street1": "331 TREBLE COVE ROAD", "city": "NORTH BILLERICA", "state": "MA", "zip": "01862"}}
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
July 3, 2013
LANTHEUS MEDICAL IMAGING, INC.
(Exact name of registrant as specified in its charter)
Delaware
333-169785
51-0396366
(State or   other jurisdiction of incorporation)
(Commission   File Number)
(IRS   Employer Identification No.)
331 Treble Cove Road, North Billerica, MA 01862
(Address of principal executive offices) (Zip code)
Registrant's telephone number, including area code:
(978) 671-8001
Not Applicable
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 1.01
Entry into a Material Definitive Agreement.
On July 3, 2013, the registrant, Lantheus Medical Imaging, Inc. (the "Company"), entered into an Amended and Restated Credit Agreement dated as of July 3, 2013 (the "New Facility"), by and among the Company, as borrower, Lantheus MI Intermediate, Inc., the
immediate
parent of the Company ("Lantheus Intermediate")
and
Lantheus MI Real Estate, LLC, a subsidiary of the Company ("Lantheus Real Estate"), each as guarantors, and Wells Fargo Bank, National Association, a national banking association ("Wells Fargo"), as sole
lead arranger, bookrunner, administrative agent and syndication agent
,
consisting of a revolving credit facility in an aggregate principal amount not to exceed
$42.5 million.
The revolving loans
under the New Facility bear interest
subject to a pricing grid based on average historical excess availability under the New Facility, with pricing based from time to time at the election of the Company at (i)
LIBOR plus
a spread ranging from 2.00% to 2.50%
or
(ii)
the Reference Rate (as defined in the agreement) plus
a spread ranging from 1.00% to 1.50%
.  The New Facility also includes an unused line fee of 0.375% or 0.5%, depending on the average unused revolving credit commitments.  The New Facility expires on
the earlier of (i)
July 3, 2018
or (ii) if the outstanding 9.750% senior notes due in 2017 are not refinanced in full, the date that is 91 days before the maturity thereof,
at which time all outstanding borrowings are due and payable
.
The New Facility is secured by a pledge of substantially all of the
assets of each of the Company, Lantheus Intermediate and Lantheus Real Estate, including each such entity's inventory, accounts receivable and machinery and equipment
,
and is guaranteed
by each of Lantheus Intermediate and Lantheus Real Estate.  Borrowing capacity is determined by reference to a borrowing base
, which is based on (i) a percentage
of
certain eligible
accounts receivable, inventory
and
machinery and equipment minus
(ii) any
reserves.  As of July 3, 2013, the aggregate borrowing base was approximately $38.4 million, with an outstanding $9.2 million unfunded Standby Letter of Credit and an $8
.0
million loan balance for net borrowing base availability of approximately $21.2 million.
The New Facility contains affirmative and negative covenants, as well as restrictions on the ability of Lantheus Intermediate, the Company and the Company's subsidiaries to: (i) incur additional indebtedness or issue preferred stock; (ii) repay subordinated indebtedness prior to its stated maturity; (iii) pay dividends on, repurchase or make distributions in respect of capital stock or make other restricted payments; (iv) make certain investments; (v) sell certain assets; (vi) create liens; (vii) consolidate, merge, sell or otherwise dispose of all or substantially all of the Company
'
s assets; and (viii) enter into certain transactions with the Company
'
s affiliates.  The New Facility also contains customary default provisions as well as cash dominion provisions which allow the lender to
sweep
the Company's accounts
during
the period
certain specified events of default are continuing
under the New Facility or excess availability under the New Facility falls below
(i)
15% of the then-current borrowing base
for a period of more than five consecutive Business Days or (ii) $3.5 million
.
During
a cash dominion period, the Company is required to comply with a consolidated fixed charge coverage
ratio
of not less than 1:00:1:00.  The fixed charge coverage ratio is calculated
on a consolidated basis for Lantheus Intermediate and its subsidiaries for a trailing four-fiscal quarter period basis,
as (
i
) EBITDA minus capital expenditures minus certain restricted payments
divided by
(
ii
) interest
plus
taxes
paid or
payable
2
in cash plus
certain restricted payments
made in cash plus
scheduled principal payments
paid or payable in cash
.
3
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
LANTHEUS MEDICAL   IMAGING, INC.
By:
/s/ Michael P.   Duffy
Name:
Michael P. Duffy
Title:
Vice President and   Secretary
Date:  July 10, 2013
4